Literature DB >> 29671078

Palliative Care in Heart Failure.

Abhinav Sood1, Krista Dobbie2, W H Wilson Tang1.   

Abstract

PURPOSE OF REVIEW: This review illustrates the dynamic role of palliative care in heart failure management and encapsulates the commonly utilized pharmacologic and non-pharmacologic therapeutic strategies for symptom palliation in heart failure. In addition, we provide our experience regarding patient care issues common to the domain of heart failure and palliative medicine which are commonly encountered by heart failure teams. RECENT
FINDINGS: Addition of palliative care to conventional heart failure management plan results in improvement in quality of life, anxiety, depression, and spiritual well-being among patients. Palliative care should not be confused with hospice care. Palliative care teams should be involved early in the care of heart failure patients with the aims of improving symptom palliation, discussing goals of care and improving quality of life without compromising utilization of evidence-based heart failure therapies. A consensus on the appropriate timing of involvement and evidence for many symptom palliation therapies is still emerging.

Entities:  

Keywords:  Advanced heart failure; Goals of care; Heart failure; Palliative care

Year:  2018        PMID: 29671078     DOI: 10.1007/s11936-018-0634-y

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  77 in total

Review 1.  Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.

Authors:  A Dewey; C Baughan; T Dean; B Higgins; I Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  Circulation       Date:  2016-05-20       Impact factor: 29.690

3.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.

Authors:  L Gullestad; P Aukrust; T Ueland; T Espevik; G Yee; R Vagelos; S S Frøland; M Fowler
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

4.  Ethical analysis of withdrawing ventricular assist device support.

Authors:  Paul S Mueller; Keith M Swetz; Monica R Freeman; Kari A Carter; Mary Eliot Crowley; Cathy J Anderson Severson; Soon J Park; Daniel P Sulmasy
Journal:  Mayo Clin Proc       Date:  2010-06-28       Impact factor: 7.616

5.  Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

Authors:  David C Currow; Christine McDonald; Sheila Oaten; Bernadette Kenny; Peter Allcroft; Peter Frith; Michael Briffa; Miriam J Johnson; Amy P Abernethy
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

6.  Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.

Authors:  Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip Poole-Wilson; Claude Le Pen
Journal:  Eur Heart J       Date:  2005-04-12       Impact factor: 29.983

7.  A closer look: Alternative pain management practices by heart failure patients with chronic pain.

Authors:  Deborah Dillon McDonald; Christina Soutar; Maria Agudelo Chan; Angela Afriyie
Journal:  Heart Lung       Date:  2015-06-16       Impact factor: 2.210

8.  Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.

Authors:  Stephen G Oxberry; J Martin Bland; Andrew L Clark; John G Cleland; Miriam J Johnson
Journal:  J Palliat Med       Date:  2013-01-31       Impact factor: 2.947

Review 9.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

10.  Serotonergic mechanisms are necessary for central respiratory chemoresponsiveness in situ.

Authors:  Andrea E Corcoran; George B Richerson; Michael B Harris
Journal:  Respir Physiol Neurobiol       Date:  2013-02-27       Impact factor: 1.931

View more
  2 in total

1.  Fentanyl Infusion Is Effective in the Treatment of Dyspnea in End-Stage Heart Failure With Renal Failure: A Case Report.

Authors:  Ryo Sakamoto; Atsuko Koyama
Journal:  Cureus       Date:  2021-01-13

Review 2.  Medical management of acute heart failure.

Authors:  Hayaan Kamran; W H Wilson Tang
Journal:  Fac Rev       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.